Journal profile · ONCOLOGY-GENETICS & HEREDITY
Cancer Genetics
ISSN 2210-7762 · eISSN 1873-4456 · Elsevier BV · UNITED STATES · Founded 2011
Cancer Genetics: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 10.82; hybrid open access; APC about USD 3,320; median 74 days to acceptance (106 articles, last 24 months); community-reported acceptance: fairly easy; 221 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Cancer Genetics is published by Elsevier BV and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cancer Genomics and Diagnostics, Acute Myeloid Leukemia Research and Genomic variations and chromosomal abnormalities, together about 31.2% of its articles. Its main subfields are Genetics. (generated from OpenAlex topic counts and CAS ranking data)
The aim of Cancer Genetics is to publish high quality scientific papers on the cellular, genetic and molecular aspects of cancer, including cancer predisposition and clinical diagnostic applications. Specific areas of interest include descriptions of new chromosomal, molecular or epigenetic alterations in benign and malignant diseases; novel laboratory approaches for identification and characterization of chromosomal rearrangements or genomic alterations in cancer cells; correlation of genetic changes with pathology and clinical presentation; and the molecular genetics of cancer predisposition. To reach a basic science and clinical multidisciplinary audience, we welcome original full-length articles, reviews, meeting summaries, brief reports, and letters to the editor.Cancer Genetics is proud to be affiliated with the Cancer Genomics Consortium.
From the journal's Aims & Scope
Research area (LetPub): ONCOLOGY-GENETICS & HEREDITY
Editor-in-chief Shashikant KulkarniPublisher website
Editorial board by country: none in mainland China; most named United States 27, Germany 3, Finland 3, United Kingdom 2, Italy 1 (36 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology13.8%
- Acute Myeloid Leukemia ResearchMedicine9.6%
- Genomic variations and chromosomal abnormalitiesBiochemistry, Genetics and Molecular Biology7.8%
- Acute Lymphoblastic Leukemia researchMedicine5.5%
- Chronic Myeloid Leukemia TreatmentsMedicine5.2%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance4.9%
- Genetic factors in colorectal cancerMedicine4.7%
- Chronic Lymphocytic Leukemia ResearchMedicine4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Genetics & Heredity | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
| Minor | Genetics & Heredity | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Genetics & Heredity | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 10.82LetPub ·
- Impact factor (publisher)
- 11Publisher website ·
- CiteScore 2026-06
- 5.5LetPub ·
- CiteScore (publisher)
- 5.5Publisher website ·
- SJR 2026-06
- 1.25LetPub ·
- SNIP 2026-06
- 1.21LetPub ·
- h-index
- 35LetPub ·
- h-index
- 66OpenAlex ·
- i10-index
- 574OpenAlex ·
- 2-year mean citedness
- 3.44OpenAlex ·
- Self-citation rate
- 0.9%LetPub ·
- Share of gold OA articles
- 18.23%LetPub ·
Volume
- Articles per year
- 116LetPub ·
Articles by year OpenAlex count · 2,576 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 85 | 28 | 16 |
| 2025 | 221 | 49 | 540 |
| 2024 | 128 | 16 | 938 |
| 2023 | 162 | 17 | 650 |
| 2022 | 305 | 31 | 536 |
| 2021 | 148 | 23 | 711 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
74 daysMedian, submission to acceptance · P25–P75 45 days – 108 days
- Acceptance to online
- median 1 days (106 articles)
- Submission to online
- median 77 days
- Sample
- 106 articles with submission and acceptance dates (228 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Submission to first decision
- 1 daysPublisher website ·
- First decision after review
- 30 daysPublisher website ·
- Submission to acceptance
- 73 daysPublisher website ·
- Acceptance to publication
- 2 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,320 / EUR 3,110 / GBP 2,660 / JPY 411,780 | — | — | |
| Publisher website | USD 3,590 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare7 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 1–7
- Reference style
- Vancouver
- Suggested reviewers
- Required
- Highlights
- Required
- Graphical abstract
- Required
- Cover letter
- Required
Article types accepted8
- book reviewArticle types DescriptionReview article Substantial overview of original research, usually with a comprehensive reference list. Note: Not a book review. Maximum…Length not stated
- case reportArticle types DescriptionReview article Substantial overview of original research, usually with a comprehensive reference list. Note: Not a book review. Maximum…Length not stated
- letterArticle types DescriptionReview article Substantial overview of original research, usually with a comprehensive reference list. Note: Not a book review. Maximum…Length not stated
- mini reviewArticle types DescriptionReview article Substantial overview of original research, usually with a comprehensive reference list. Note: Not a book review. Maximum…Length not stated
- original researchArticle types DescriptionReview article Substantial overview of original research, usually with a comprehensive reference list. Note: Not a book review. Maximum…Length not stated
- original research articleArticle types DescriptionReview article Substantial overview of original research, usually with a comprehensive reference list. Note: Not a book review. Maximum…Length not stated
- review articleReview article Substantial overview of original research, usually with a comprehensive reference list. Note: Not a book review. Maximum number (combined) of tab…Length not stated
- short communicationArticle types DescriptionReview article Substantial overview of original research, usually with a comprehensive reference list. Note: Not a book review. Maximum…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- Publication ethics
Ethics in publishing Model summary
Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication. In support of Open Science, this journal offers its authors a free preprint posting service on SSRN, Elsevier’s preprint and early research …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier BV
- Country or region
- UNITED STATES
- Language
- English
- Founded
- 2011
- ISSN
- 2210-7762
- Electronic ISSN
- 1873-4456
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Cancer Genetics
What CAS zone is Cancer Genetics in?
In the 2025 upgraded edition of the CAS Journal Ranking, Cancer Genetics is in Zone 4 of Medicine, and in Zone 4 of the minor category Genetics & Heredity / Oncology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Cancer Genetics?
The latest impact factor listed by LetPub is 10.82; CiteScore 5.5, h-index 66.
How long does peer review take at Cancer Genetics?
Based on the dates recorded on 106 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 74 days (interquartile range 45–108 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Cancer Genetics?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7; Reference style: Vancouver; Suggested reviewers: Required; Highlights: Required; Graphical abstract: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Cancer Genetics based?
Of the 36 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (27), Germany (3) and Finland (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Cancer Genetics?
According to LetPub and DOAJ records, Cancer Genetics is indexed in SCIE and Scopus.
Is Cancer Genetics open access, and what is the APC?
Cancer Genetics is a hybrid journal. For open-access publication: APC about USD 3,320.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .